Cardiac Allograft Hypertrophy: A New Target for Therapy, a Surrogate Marker for Survival? - American Journal of Transplantation
Surrogate Markers of Chronic Allograft Nephropathy in Man - ppt download
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Surrogate endpoints: a regulatory review
![PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ae9f320037de4f081b4772e3245508f1d8bc6b3/3-Figure1-1.png "PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar")
PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Table I from Surrogate markers in HIV disease. | Semantic Scholar
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Information Theory–Based Surrogate Marker Evaluation from Several Randomized Clinical Trials with Binary Endpoints, Using SAS: Journal of Biopharmaceutical Statistics: Vol 18, No 2
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
surrogate markers - List of Frontiers' open access articles
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
Surrogate Endpoints and Biomarkers | Basicmedical Key
Defining vitamin D deficiency, using surrogate markers – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink
MRI as a surrogate marker for clinical outcomes in multiple sclerosis | Personalized Management of Multiple Sclerosis
Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
Tympanic membrane pressure (TMP) as a surrogate marker of intracranial... | Download Scientific Diagram
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Surrogate Markers of Vision* | Download Table
Pharmacodynamic markers and surrogate endpoints are a subset of... | Download Scientific Diagram
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity
